Vaidya Sane Ayurved Laboratories Complete Financial Statements
MADHAVBAUG • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2024 - 2022
Complete Financial Data Export
Export complete financial statements for Vaidya Sane Ayurved Laboratories (MADHAVBAUG).
Downloads include all available records across all periods.
For market performance, see the
MADHAVBAUG stock price today
.
Profitability Ratios
Net Profit Margin
4.54%
2023 data
EBITDA Margin
6.42%
2023 data
Operating Margin
5.00%
2023 data
Return on Assets
330.99%
2023 data
Return on Equity
419.64%
2023 data
Balance Sheet Ratios
Current Ratio
34.00
2023 data
Debt to Equity
1.27
2023 data
Equity Ratio
78.87%
2023 data
Asset Turnover
72.86
2023 data
Year-over-Year Growth Analysis
Comparing Sept 2022 vs Sept 2023
Revenue Growth
-48.5%
Year-over-Year
Net Profit Growth
-75.7%
Year-over-Year
EBITDA Growth
-64.0%
Year-over-Year
Expense Growth
-47.0%
Year-over-Year
Assets Growth
+29.1%
Year-over-Year
Equity Growth
+36.6%
Year-over-Year
Liabilities Growth
+29.1%
Year-over-Year
Investing Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
+1600.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2023 | Jun 2023 | Sept 2022 |
|---|---|---|---|
| Revenue | 5,173 | 4,641 | 10,053 |
| Expenses | 4,842 | 4,142 | 9,131 |
| EBITDA | 332 | 500 | 922 |
| Operating Profit Margin % | 5.00% | 9.00% | 8.00% |
| Depreciation | 159 | 116 | 260 |
| Interest | 16 | 11 | 19 |
| Profit Before Tax | 157 | 373 | 643 |
| Tax | -78 | 126 | -323 |
| Net Profit | 235 | 247 | 967 |
| Earnings Per Share (₹) | 1.12 | 2.60 | 4.60 |
Related Pages for Vaidya Sane Ayurved Laboratories
Additional stock information and data for MADHAVBAUG
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2024 | 2023 |
|---|---|---|
| ASSETS | ||
| Total Assets | 71 | 55 |
| Current Assets | 34 | 28 |
| Fixed Assets | 28 | 21 |
| Capital Work in Progress | 3 | 2 |
| Investments | 2 | 14 |
| Other Assets | 38 | 19 |
| LIABILITIES | ||
| Total Liabilities | 71 | 55 |
| Current Liabilities | 1 | 2 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 56 | 41 |
| Share Capital | 11 | 11 |
| Reserves & Surplus | 32 | 30 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2024 | March 2023 |
|---|---|---|
| Operating Activities | -4 | 0 |
| Investing Activities | 2 | 1 |
| Financing Activities | 15 | -1 |
| Net Cash Flow | 12 | -1 |